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ox5
 
 and 
 
Sox6
 
 encode 
 
Sry
 
-related transcription factors
that redundantly promote early chondroblast differ-
entiation. Using mouse embryos with three or four
null alleles of 
 
Sox5 
 
and
 
 Sox6,
 
 we show that they are also
essential and redundant in major steps of growth plate
chondrocyte differentiation. 
 
Sox5 
 
and 
 
Sox6
 
 promote the
development of a highly proliferating pool of chondroblasts
between the epiphyses and metaphyses of future long
bones. This pool is the likely cellular source of growth
plates. 
 
Sox5
 
 and 
 
Sox6
 
 permit formation of growth plate
S
 
columnar zones by keeping chondroblasts proliferating
and by delaying chondrocyte prehypertrophy. They allow
induction of chondrocyte hypertrophy and permit formation
of prehypertrophic and hypertrophic zones by delaying
chondrocyte terminal differentiation induced by ossiﬁcation
fronts. They act, at least in part, by down-regulating Ihh
signaling, 
 
Fgfr3,
 
 and 
 
Runx2
 
 and by up-regulating 
 
Bmp6
 
. In
conclusion, 
 
Sox5
 
 and 
 
Sox6
 
 are needed for the establishment
of multilayered growth plates, and thereby for proper and
timely development of endochondral bones.
 
Introduction
 
Cartilage has essential roles in endochondral ossification, a
multistep process whereby most bones develop in vertebrates.
This process starts in the embryo with the formation of
cartilage primordia that already prefigure definitive bones.
These primordia then develop growth plates that enlarge
skeletal elements and are progressively replaced by bone
from fetal stages until adulthood.
Cartilage primordia arise upon condensation of pre-
chondrogenic mesenchymal cells. These cells differentiate
sequentially into prechondrocytes and chondroblasts. Pre-
chondrocytes activate 
 
Col2a1
 
 (collagen type 2), 
 
Agc1
 
 (aggre-
can), and other cartilage-specific extracellular matrix genes.
Chondroblasts up-regulate these genes and activate others
like 
 
Mat1
 
 (matrilin-1). They produce large amounts of ex-
tracellular matrix and actively proliferate. Several types of
signaling molecules and transcription factors control skele-
ton patterning and cell differentiation at these early stages
(DeLise et al., 2000; Hall and Miyake, 2000; de Crombrug-
ghe et al., 2001; Karsenty and Wagner, 2002). The latter
include three Sry-related HMG box-containing proteins,
L-Sox5, Sox6, and Sox9. L-Sox5 (a long product of 
 
Sox5
 
)
and Sox6 are highly identical to each other but related to
Sox9 only in the HMG box DNA-binding domain (Lefeb-
vre, 2002). 
 
Sox5
 
, 
 
Sox6
 
, and 
 
Sox9
 
 are coexpressed in all carti-
lage primordia of the mouse embryo and may cooperate to
directly activate 
 
Col2a1
 
 (Ng et al., 1997; Zhao et al., 1997;
Lefebvre et al., 1998). 
 
Sox9
 
 is required for prechondrogenic
cell condensation, prechondrocyte and chondroblast differ-
entiation, and activation of 
 
Sox5
 
, 
 
Sox6
 
, and cartilage matrix
genes (Bi et al., 1999; Akiyama et al., 2002). 
 
Sox5
 
 and 
 
Sox6
 
have essential, redundant roles in early chondroblasts (Smits
et al., 2001). Although 
 
Sox5
 
 
 
/
 
 
 
 and 
 
Sox6
 
 
 
/
 
 
 
 mice are born
with minor cartilage defects, 
 
Sox5
 
 
 
/
 
 
 
/
 
Sox6
 
 
 
/
 
 
 
 embryos de-
velop a severe, generalized chondrodysplasia due to consider-
able delay and impairment of chondroblast proliferation and
expression of cartilage matrix genes. They die around em-
bryonic day 16.5 (E16.5) with rudimentary and matrix-defi-
cient cartilage primordia.
The fate of each chondroblast is determined by its loca-
tion in cartilage primordia (Karsenty and Wagner, 2002;
Kronenberg, 2003). Although epiphyseal chondroblasts are
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maintained at an early differentiation stage throughout ges-
tation, diaphyseal and metaphyseal chondroblasts mature to
form growth plates and induce the formation of primary os-
sification centers. Upon undergoing prehypertrophy, they
stop proliferating and sequentially activate 
 
Ppr
 
 (receptor
for parathyroid hormone and parathyroid hormone–related
peptide), 
 
Ihh
 
 (Indian hedgehog), and 
 
Col10a1
 
 (collagen type
10). They also induce the flanking perichondrium to form a
bone collar. Next, they undergo hypertrophy, stop express-
ing 
 
Col2a1
 
, 
 
Agc1
 
, and other early markers, progressively
down-regulate 
 
Ppr
 
 and 
 
Ihh
 
, up-regulate expression of
 
Col10a1
 
, and induce cartilage matrix mineralization. As they
terminally differentiate, they stop expressing 
 
Col10a1
 
, acti-
vate 
 
Opn
 
 (osteopontin) and 
 
Mmp13
 
 (matrix metalloprotein-
ase-13), and undergo apoptosis. Bone collar chondro/osteo-
clasts, osteoblasts, and blood vessels then invade and replace
the cartilage by bone. Various signaling molecules control
these processes. They include Ihh, PTHrP (parathyroid hor-
mone–related peptide), and PPR (Karaplis et al., 1994; Lan-
ske et al., 1996; Vortkamp et al., 1996; St-Jacques et al.,
1999), FGFR3 (fibroblast growth factor receptor-3) and its
ligand FGF18 (Colvin et al., 1996; Deng et al., 1996; Liu et
al., 2002; Ohbayashi et al., 2002), bone morphogenetic pro-
teins (BMPs; Zou et al., 1997), and Wnt proteins (Hart-
mann and Tabin, 2000; Yang et al., 2003). Few transcrip-
tion factors have yet been demonstrated to control these
processes. 
 
Cbfa1/Runx2
 
 is expressed in late chondroblasts
 
and in prehypertrophic and hypertrophic chondrocytes (In-
ada et al., 1999; Kim et al., 1999). It induces prehypertro-
phy as shown by a block of chondrocyte differentiation be-
fore prehypertrophy in several skeletal elements of 
 
Runx2
 
 
 
/
 
 
 
mouse embryos and by maturation of transgenic chondro-
blasts forced to express 
 
Runx2
 
 (Takeda et al., 2001). How-
ever, because 
 
Runx2
 
 
 
/
 
 
 
 chondrocytes properly mature in
some skeletal elements, additional factors must contribute to
induce chondrocyte maturation. 
 
Sox5
 
,
 
 Sox6
 
, and 
 
Sox9
 
 are
turned off upon chondrocyte prehypertrophy (Lefebvre et
al., 1998). 
 
Sox9
 
 
 
/
 
 
 
 embryos precocious mineralize cartilage
primordia and develop enlarged hypertrophic zones (Bi et
al., 2001). Thus, 
 
Sox9
 
 might delay chondrocyte hypertro-
phy. When 
 
Sox5
 
 
 
/
 
 
 
/Sox6
 
 
 
/
 
 
 
 fetuses die, their cartilage pri-
mordia contain few prehypertrophic chondrocytes but no
hypertrophic cells. They are being invaded by thick bone
collars but feature no cartilage growth plates and no ossifica-
tion centers (Smits et al., 2001). Therefore, these fetuses do
not allow for a full assessment of the roles of 
 
Sox5
 
 and 
 
Sox6
 
in the growth plate.
To determine such roles, we mostly analyzed here em-
bryos with three null alleles (3NA) of 
 
Sox5
 
 and 
 
Sox6
 
(
 
Sox5
 
 
 
/
 
 
 
/Sox6
 
 
 
/
 
 
 
 and 
 
Sox5
 
 
 
/
 
 
 
/
 
Sox6
 
 
 
/
 
 
 
). These embryos live
until birth and show severe growth plate chondrocyte de-
fects. We show that 
 
Sox5
 
 and 
 
Sox6
 
 are needed to form and
maintain a pool of highly proliferating chondroblasts be-
tween epiphyses and metaphyses, to form columnar chon-
Figure 1. Chondrodysplasia features of 3NA mice. Genotypes 
are designated as follows: 5, Sox5; 6, Sox6; w, wild type; h, 
heterozygous null; n, homozygous null. (A) Alcian blue 
staining of E14.5 embryos. Top and bottom embryos are 
from different litters. Arrows, Meckel’s cartilages; arrowhead, 
bent radius and ulna. (B) Skeletal preparations of vertebrae 
from E17.5 littermates. Alcian blue stains nonmineralized 
cartilage and alizarin red stains mineralized cartilage and 
bone. (Arrows) L1 and L6, first and sixth lumbar vertebrae, 
respectively. (C) Pictures of newborns. The first two and the 
last two mice are from separate litters. Arrows, bent hindlimbs. 
(D–G) Skeletal preparations of newborn littermates. (D) Fore-
limbs. Arrowheads, bent humeri and radii. (E) Cervical 
vertebrae. Arrows, vertebral bodies. (F) Lumbar and sacral 
vertebrae. L6, sixth lumbar vertebra; S1, first sacral vertebra. 
Arrows, vertebral bodies and arches separated by nonminer-
alized cartilage in controls and mineralized cartilage or bone 
in mutants. (G) Sternum. Arrows, intersternebrae made of 
nonmineralized cartilage in the control and mineralized bone 
or cartilage in the mutants. 
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droblasts, delay chondrocyte prehypertrophy but promote
hypertrophy, and to delay terminal differentiation of chon-
drocytes on contact with ossification fronts. 
 
Sox5
 
 and 
 
Sox6
 
act in part by controlling the domain of action and expres-
sion of major regulatory factors.
 
Results
 
Chondrodysplasia of 3NA embryos
 
By E14.5, all cartilage primordia of 3NA embryos were hy-
poplastic and weakly stained with Alcian blue (Fig. 1 A).
Some were also bent. In comparison, only the Meckel’s, cos-
tal, and a few other cartilages were hypoplastic in 2NA em-
bryos (Fig. 1 A), and all 4NA cartilage primordia were rudi-
mentary and hardly stained with Alcian blue (Smits et al.,
2001). 1NA and wild-type embryos were indistinguishable
from each other at this and later stages, and therefore were
used as controls throughout this work. The onset of miner-
alization was delayed in all 3NA endochondral skeletal ele-
ments, such as in vertebral bodies (Fig. 1 B). The two types
of 3NA mice died at birth from respiratory distress and fea-
tured virtually identical skeletal defects (Fig. 1, C–G). They
had a foreshortened snout, micrognathia, short trunk, and
short, bent limbs (Fig. 1 C). Forelimb (Fig. 1 D) and other
long bones were shorter than normal, but not always thin-
ner, and some were bent. Cervical vertebrae start to ossify
later than lumbar and sacral vertebrae. In 3NA newborns,
the former had not yet started to mineralize (Fig. 1 E),
whereas the latter were ectopically mineralized (Fig. 1 F).
The sternum was the most affected 3NA element (Fig. 1 G).
It was short and thick, and intersternebrae were ectopically
mineralized. Thus, 3NA embryos developed generalized car-
tilage primordium hypoplasia and skeleton growth and min-
eralization defects that strongly suggested roles for 
 
Sox5
 
 and
 
Sox6
 
 in chondrocyte maturation.
 
Precocious prehypertrophy of chondrocytes in 3 and 
4NA cartilage primordia
 
3NA chondroblasts started to differentiate with a significant
delay compared with control cells but ultimately formed
close-to-normal cartilage primordia. For instance, 3NA tibia
chondroblasts were surrounded by less cartilage extracellular
matrix and were expressing 
 
Agc1
 
 at a lower level than control
cells at E13.5 (Fig. 2 A). In contrast, 3NA humerus chon-
droblasts, which develop earlier, were expressing 
 
Agc1
 
 and
other markers at close-to-normal levels and had accumulated
a fair amount of cartilage matrix (Fig. 2 B). The onset of
chondrocyte prehypertrophy was delayed in all 3NA carti-
lage primordia, as seen for 
 
Ppr
 
 activation in E13.5 tibias. In-
terestingly, once the first core cells became prehypertrophic,
their neighbors became prehypertrophic more rapidly in
mutants than in controls, as seen for 
 
Ppr
 
 and 
 
Col10a1
 
 acti-
vation in E13.5 humeri. The sternum was the most affected
3NA element (Fig. 2 C). Sternebral but not intersternebral
chondroblasts were prehypertrophic in E16.5 control ster-
nums, as seen by cell enlargement and 
 
Ppr
 
 expression. In
contrast, both sternebral and intersternebral chondrocytes
were already prehypertrophic in 3NA sternums. 4NA hu-
meri were poorly developed by E14.5 (Fig. 2 D). The ex-
pression domain of 
 
Mat1
 
, a marker of both chondroblasts
and prehypertrophic chondrocytes, was wide in control hu-
meri and overlapped only partially with that of 
 
Ppr
 
. In con-
trast, few cells were expressing 
 
Mat1
 
 in 4NA humeri and
most of them were also expressing 
 
Ppr
 
. Thus, these data
Figure 2. Premature prehypertrophy 
of 3NA and 4NA chondroblasts. Longi-
tudinal sections through the tibias (A), 
humeri (B and D), or sternums (C) of E13.5 
to E16.5 control and mutant embryos were 
stained with Alcian blue or hybridized in 
situ with RNA probes, as indicated. 
White bars, prehypertrophic chondrocyte 
domains. Sternum prehypertrophic 
chondrocytes are recognized by a white 
cytoplasm. Arrows, sternebrae. For E14.5 
humeri, the control proximal half and 
the entire mutant element are shown. 
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demonstrated that 
 
Sox5
 
 and 
 
Sox6
 
 are needed to prevent
chondroblast premature prehypertrophy.
 
Delayed chondrocyte hypertrophy and terminal 
differentiation in 3NA cartilage primordia
 
By E14.5, chondrocytes in the core regions of control hu-
meri still exhibited a moderate size, typical of prehyper-
trophic cells, but they had already induced matrix mineral-
ization (Fig. 3 A). They had inactivated 
 
Ppr, were still
expressing  Col10a1, and had activated Opn and Mmp13
(Fig. 3 B). Thus, these chondrocytes had rapidly progressed
from prehypertrophy to terminal differentiation. Flanking
chondrocytes were fully enlarged, had induced cartilage
mineralization, and were expressing Col10a1 at the highest
level. Thus, they were overtly hypertrophic. Both core and
flanking cells were surrounded with a mineralized bone col-
lar in which osteoclasts were expressing Mmp9. Mmp9-posi-
tive cells were also detected in the cartilage core, indicating
the onset of endochondral ossification. In 3NA humeri,
both core and flanking cells were still prehypertrophic. In-
deed, they were moderately enlarged, were not mineraliz-
ing the cartilage matrix, were expressing Ppr strongly and
Col10a1 weakly, and were not expressing Mmp13. The peri-
chondrium had not developed into a mineralized bone collar
but contained Mmp9-expressing osteoclasts. Interestingly,
chondrocytes expressing Opn were found adjacent to the
bone collar and were thus terminally differentiating. By
E15.0, the core of control humeri was ossifying (Fig. 3, C
and D). It contained Mmp9-expressing osteoclasts/chondro-
clasts and cells expressing Opn and Mmp13, which were ei-
ther terminal chondrocytes or mature osteoblasts. The core
of 3NA humeri was still cartilaginous, but its cells were ter-
minally differentiating as seen by Ppr inactivation and Opn
and Mmp13 activation. The cartilage matrix was mineralized
only next to the bone collar and was starting to be invaded
by bone. By E15.5, the 3NA humerus core was fully ossified
(Fig. 4 A). Thus, 3NA chondrocytes were delayed and im-
paired in undergoing hypertrophy but terminally differenti-
ating next to ossification fronts.
Defective columnar and hypertrophic zones in 3NA 
growth plates
To determine the roles of Sox5 and Sox6 in established
growth plates, we compared the development of control and
3NA humeri from E13.5 until birth by measuring the elon-
gation of their epiphyses, columnar and hypertrophic re-
gions, and primary ossification centers (Fig. 4 A). The hy-
pertrophic region was defined by enlarged cells, and thus
contained late prehypertrophic, hypertrophic, and terminal
chondrocytes. The columnar region contained metaphyseal
chondroblasts and early prehypertrophic chondrocytes. Mu-
tant and control humeri were similar at E13.5 (Fig. 4 B).
From that time on, mutant epiphyses elongated at the same
rate as controls. In contrast, the mutant columnar and hy-
pertrophic zones became dramatically smaller than the con-
trols, remaining only at 43% and 63% of the height of the
respective control zones at birth. The mutant bone segments
grew at 65–70% of the rate of controls. High magnification
pictures of newborn humerus sections showed that the
shortness of the mutant columnar region was not due to a
Figure 3. Delayed hypertrophy and termi-
nal differentiation of 3NA chondrocytes. 
(A and C) Longitudinal sections through the 
shaft of control and 3NA humeri from E14.5 
and E15.0 littermates stained with Alcian 
blue (top) or the von Kossa reagent (bottom). 
The von Kossa reaction identifies mineral 
deposits (black signal). (insets) High-magni-
fication pictures showing the size of chon-
drocytes in the core region at E14.5 and in 
the flanking region at E15.0 (Alcian blue), 
and the extent of cartilage mineralization next 
to the bone collar (von Kossa). (B and D) 
Sections adjacent to those shown in A and 
C hybridized in situ with RNA probes, as 
indicated. The hybridization signal for 
Col10a1 is so strong in the E14.5 control 
hypertrophic zone that it appears black. P, 
prehypertrophic zone; H, hypertrophic zone; 
T, terminal zone; B, primary ossification 
center.Sox5 and Sox6 control growth plate chondrocytes | Smits et al. 751
more compact cell organization or a failure of the cells to or-
ganize into columns (Fig. 4 C). The mutant region con-
tained half as many cell layers as the control, corresponding
to the height reduction. In contrast, the mutant hyper-
trophic zone contained 25% fewer cell layers but was 37%
shorter than normal. Therefore, its reduced height was in
part due to the smaller size of the cells. We measured that
mutant hypertrophic cells were on average 83% as high as
control cells in the four layers abutting the ossification front.
Because endochondral bone forms by replacement of these
layers and because 3NA bone was expanding at 65–70% of
the normal rate, the 3NA bone grew slowly not only because
hypertrophic chondrocytes were smaller but probably also
because terminal chondrocytes died at a slower rate. To-
gether with the absence of columnar and hypertrophic cells
in 4NA elements (Smits et al., 2001), these data demon-
strate that Sox5 and Sox6 ensure optimal growth of endo-
chondral bones by specifically promoting the formation and
maintenance of columnar and hypertrophic chondrocytes.
Reduced proliferation and precocious prehypertrophy 
of 3NA growth plate chondroblasts
The size of the columnar region is determined by the rate
of cell proliferation within this zone and by the rate at
which chondroblasts exit this zone to become hypertro-
phic. It may also depend on the rate at which epiphyseal
chondroblasts enter this zone (Kobayashi et al., 2002). To
measure the rate of chondroblast proliferation, we labeled
proliferating cells in vivo with BrdU and counted the per-
centages of positive cells in small segments juxtaposed from
the presumptive joint to the center of cartilage primordia
or to the hypertrophic zone of growth plates (Fig. 5). We
found that control chondroblasts proliferated at highly
variable rates in different subregions of epiphyses and
growth plates. They proliferated at the highest levels at the
top of metaphyses both in E13.5 (Fig. 5 A) and in E16.5
humeri (Fig. 5 B). Interestingly, 3NA chondroblasts were
consistently found to proliferate slower than control cells
in this region. At E13.5, the rate of cell proliferation de-
creased from this peak toward the presumptive joint, where
prechondrocytes were still differentiating, and toward the
Figure 4. Defective growth plates in 3NA humeri. (A) Longitudinal 
sections in control and 3NA E15.5 humeri stained with Alcian blue. 
Four histological regions are recognized: E, epiphysis; C, columnar 
region; H, hypertrophic region; B, primary ossification center. (B) 
Relative growth of the histological regions in control and 3NA 
humerus proximal halves from E13.5 to birth (P0). Pictures of 
humerus sections were taken at identical magnification for all 
samples. The distance between the middle of the humerus and the 
proximal limit of each region was measured for two to four different 
mice per genotype and per age. The averages of these distances were 
calculated per mouse category and are presented relative to the 
length of the proximal half of newborn control humeri, which was 
assigned a value of 100. The curves connect the values measured for 
each region (indicated underneath the curves) from E13.5 or E15.5 
to birth. (C) Longitudinal sections of control and 3NA humerus heads 
stained with Alcian blue. Brackets show the epiphysis (E), columnar 
(C), and hypertrophic (H) regions. Bottom left, high magnification 
pictures of cells in these regions. The table indicates the number of 
cell layers in each region for one representative embryo pair as the 
average with SD of measurements made in three nonconsecutive 
sections.
Figure 5. Slow proliferation of 3NA chondroblasts. (A and B) BrdU 
labeling and cell proliferation rates in control and 3NA humeri in 
E13.5 and E16.5 embryos. Pictures show longitudinal sections of 
humeri stained for BrdU (brown nuclei). The percentages of BrdU-
positive chondroblasts were determined in the consecutive segments 
delineated with black lines and plotted in the graphs. The arrows in 
the graph indicate that the cells enlarging the distal half of epiphyses 
and elongating humeri shafts primarily arise from cells proliferating 
maximally at the top of metaphyses, and that cells in the proximal half 
of E16.5 epiphyses arise from cells highly proliferating in periarticular 
regions. Ep, epiphysis; M, metaphysis; Ce, center; Col, columnar zone.752 The Journal of Cell Biology | Volume 164, Number 5, 2004
center of the cartilage primordia, where chondroblasts were
undergoing prehypertrophy. 3NA cells were proliferating
at a lower rate than controls in epiphyses, likely reflecting
their chondroblastic delay. At E16.5, chondroblasts were
proliferating more slowly in the middle than in the periph-
ery of epiphyses, but no major difference was seen between
controls and mutants. The columnar zone was character-
ized by a progressive decline in cell proliferation, and this
decline occurred twice as fast in 3NA humeri as in con-
trols. Thus, 3NA chondroblasts formed shorter columnar
zones because they failed to proliferate fast enough at the
top of this zone and because they growth arrested faster
than normal. The unaffected proliferation rate of 3NA epi-
physeal chondroblasts was consistent with the normal
growth rate of epiphyses, indicating that these cells un-
likely contributed to the shortness of the columnar zone.
Inability of chondrocytes to undergo overt hypertrophy 
in 3NA and 4NA long bone growth plates
Because chondrocytes no longer proliferate beyond early pre-
hypertrophy, the number of cell layers in the hypertrophic
region only reflects the time spent by the cells in this region.
We determined if 3NA cells proceeded faster through late
prehypertrophy, hypertrophy, or terminal differentiation by
analyzing expression of stage-specific markers (Fig. 6 A). In
newborn control humeri, Ppr is highly expressed in prehy-
pertrophic chondrocytes and weakly expressed in hyper-
trophic and terminal cells. In 3NA humeri, its high expres-
sion domain was slightly reduced and its low expression
domain strongly reduced. Col10a1 is highly expressed in pre-
hypertrophic and hypertrophic chondrocytes and turned off
in terminal chondrocytes. Its expression domain was strongly
reduced in mutants. The terminal chondrocyte marker
Mmp13 was similarly expressed in control and mutant
growth plates. von Kossa staining revealed cartilage mineral-
ization around several layers of lower hypertrophic and ter-
minal chondrocytes in controls, but only around terminal
chondrocytes in mutants. Thus, the shortening of the 3NA
hypertrophic region was mostly due to reduction of the hy-
pertrophic zone. In E15.5 4NA humeri (Fig. 6 B), Mmp13
was expressed in cells lining the bone collar and Ppr was ex-
pressed in cells adjacent to them. There was no Col10a1 ex-
pression and no cartilage matrix mineralization. Thus, 4NA
cells were terminally differentiating immediately after reach-
ing prehypertrophy. Thus, Sox5 and Sox6 promote chondro-
cyte hypertrophy and prevent terminal differentiation of pre-
hypertrophic and hypertrophic cells.
Absence of growth plates in 3NA sternum and vertebrae
Control lumbar vertebrae featured short, bidirectional growth
plates flanking the ossification centers of vertebral bodies
and neural arches (Fig. 7 A). In contrast, growth plates were
lacking in 3NA vertebrae and replaced with cartilage-min-
eralizing fully hypertrophic cells. Control sternums fea-
tured ossified sternebrae and intersternebral growth plates,
whereas 3NA sternebrae and intersternebrae were both
mostly filled with fully enlarged, matrix-mineralizing chon-
drocytes (Fig. 7 B). These cells were hypertrophic or
terminally differentiated, expressing Col10a1 and Mmp13,
whereas the other chondrocytes were prehypertrophic, ex-
pressing Ppr and Ihh (Fig. 7 C). Thus, the abundance of hy-
pertrophic chondrocytes in 3NA sternums contrasted with
the reduction of hypertrophic zones in future long bones but
indicated that 3NA chondrocytes were retaining the ability
to undergo overt hypertrophy. Interestingly, 3NA sternum
chondrocytes were maturing from the ventral to the dorsal
side of the sternum, perpendicularly to the normal matura-
tion gradient. The ventral side of the 3NA sternum was
a nonmineralized perichondrium/periosteum, whereas the
dorsal side was a continuous bone collar. Thus, terminal
chondrocytes were developing against ossification fronts, as
in long bones.
Figure 6. Reduced hypertrophic zone in 
3NA growth plates. (A) Longitudinal sections 
through humeri of control and 3NA newborn 
mice. Consecutive sections were stained with 
Alcian blue or the von Kossa reagent, or 
hybridized with RNA probes, as indicated. 
Pictures focus on the lower part of growth 
plates and are aligned at the level of the 
ossification front. The von Kossa pictures 
show the last cell layers of the growth plates 
at high magnification. White arrows, expres-
sion domains of tested genes. Green arrows, 
cell layers between the gene expression 
domain and the ossification front. Blue 
arrows, layers of matrix-mineralizing chon-
drocytes. (B) Longitudinal sections through 
humeri of control and 4NA E15.5 fetuses. 
Consecutive sections were stained with 
Alcian blue or the von Kossa reagent, or 
hybridized with RNA probes, as indicated. 
Control pictures show the proximal growth 
plate of the humerus and mutant pictures 
show the entire humerus. The von Kossa 
pictures were taken at higher magnification.Sox5 and Sox6 control growth plate chondrocytes | Smits et al. 753
Changes in expression and activity of regulatory 
molecules in 3NA growth plates
Next, we determined whether or not the 3NA growth plate
defects could be explained by changes in expression or activ-
ity of known regulatory molecules. Expression of Sox9,
which may prevent chondrocyte hypertrophy, was un-
changed in 3NA growth plates (unpublished data). Expres-
sion of Runx2, which can induce chondrocyte prehypertro-
phy, was strongly up-regulated in 3NA late chondroblasts,
prehypertrophic chondrocytes, and periosteum cells in E13.5
and E14.5 humeri (Fig. 8 A). Thus, Sox5 and Sox6 may pre-
vent prehypertrophy at least in part by down-regulating
Runx2. Expression of Pthrp, which prevents chondroblast
maturation, was similar in control and 3NA periarticular
chondroblasts (Fig. 8 B). Ihh, which has major roles in the
growth plate, including stimulation of chondroblast prolifer-
ation (St-Jacques et al., 1999), was expressed at similar levels
in 3NA and control prehypertrophic chondrocytes (Fig. 8
C). However, more 3NA cells were expressing Ihh than con-
trol cells between E13.5 and E15.0 due to precocious prehy-
pertrophy and delayed hypertrophy, and fewer 3NA cells
were expressing Ihh than control cells later on due to reduc-
tion of the hypertrophic region. Interestingly, Ptc1, which
encodes an Ihh receptor and is an Ihh transcriptional target,
was up-regulated in 3NA chondroblasts, periosteum, and
primary spongiosa between E13.5 and birth (Fig. 8 D).
Moreover, although it was widely expressed in early cartilage
primordia but restricted to columnar chondroblasts in estab-
lished growth plates in control embryos, it remained widely
expressed in 3NA fetal cartilages. Thus, these Ptc1 data re-
vealed an increase in Ihh signaling that was unexpected
given the proliferation defect of 3NA chondroblasts. Hence,
Sox5 and Sox6 unlikely control chondroblast proliferation
by modulating Ihh expression or signaling. Fgf18, which is
expressed in the perichondrium and signals through FGFR3
in chondrocytes (Liu et al., 2002; Ohbayashi et al., 2002),
was expressed at a normal level in 3NA skeletal elements
(unpublished data). Fgfr3, which is expressed in columnar
chondroblasts and inhibits cell proliferation (Deng et al.,
1996; Colvin et al., 1996), was found expressed in a positive
gradient from the top to the bottom of the columnar zone in
control growth plates. Thus, this gradient was opposite to
the cell proliferation gradient. Interestingly, Fgfr3 expression
followed the same gradient in 3NA growth plates but was
up-regulated earlier (Fig. 8 E). Therefore, Sox5 and Sox6 are
likely to control chondroblast proliferation at least in part by
delaying Fgfr3 up-regulation. Bmp2, Bmp4-7, Bmpr1a, and
Bmpr1b are expressed in discrete domains in the growth
plate, perichondrium, and periosteum and interact with the
Ihh and FGF signaling pathways. Of these genes, only ex-
pression of Bmp6 was altered in 3NA elements (Fig. 8 F and
not depicted). Its expression in developing joints was un-
changed, but its expression in prehypertrophic chondrocytes
was down-regulated. Expression of Wnt5a and Wnt5b,
which control chondroblast proliferation and differentia-
tion, was not altered in 3NA growth plates (unpublished
data). As a result, Sox5 and Sox6 likely control growth plate
chondrocytes at least in part through the key regulatory mol-
ecules RUNX2, IHH, FGFR3, and BMP6.
Discussion
This work has identified multiple, essential roles for Sox5 and
Sox6 in cartilage growth plates and has allowed for a better
understanding of the development and molecular control of
these highly specialized structures. We have demonstrated
that fetal chondroblasts proliferate at the highest level be-
tween epiphyses and metaphyses of future long bones. There-
Figure 7. Vertebrae and sternum of 3NA new-
borns. (A) Transverse sections of lumbar vertebrae. 
The top section for each genotype was stained with 
Alcian blue and the bottom section with the von 
Kossa reagent. (insets) High magnification pictures 
of hypertrophic chondrocytes. NA, neural arch 
ossification center; GP, bidirectional growth plate; 
VB, vertebral body ossification center. (B) Mid-
sagittal sections of the sternum. The mouse ventral 
side is at the bottom of the pictures. The top section 
for each genotype was stained with Alcian blue and 
the bottom with the von Kossa reagent. All sections 
were from different mice. Red arrows, intersterne-
brae. bc, bone collar; p, perichondrium/periosteum. 
Black boxes, regions of the sternums shown in C. 
(C) RNA in situ hybridization of sternum mid-sagittal 
sections consecutive to those stained with Alcian 
blue in B.754 The Journal of Cell Biology | Volume 164, Number 5, 2004
fore, we propose that these cells must be the main cellular
source of growth plates. Sox5 and Sox6 are needed for the op-
timal proliferation of these cells. They are also needed to de-
velop and maintain growth plate columnar zones by allowing
chondroblasts arising from the source to decrease their pro-
liferation rate at a slow pace and delay prehypertrophy.
Although no longer expressed beyond chondrocyte pre-
hypertrophy, Sox5 and Sox6 are required for chondrocyte hy-
pertrophy and to prevent precocious terminal differentiation
of prehypertrophic and hypertrophic chondrocytes. The ob-
servation that Sox5/Sox6 mutant chondrocytes terminally dif-
ferentiate only on contact with ossification fronts suggests an
important role for ossification fronts in this last differentia-
tion step. Finally, Sox5 and Sox6 were found to act in the
growth plate at least in part through major regulatory factors.
Sox5/Sox6 3NA mice and Sox9 mutant mice
This work would not have been possible using only 4NA
mice because these mice die at  E16.5 with no true growth
plates (Smits et al., 2001). 3NA embryos constituted a good
complementary model because their generalized chondrodys-
plasia is mainly due to growth plate defects. Their chondro-
cytes are defective at many differentiation steps but do not
arrest at any specific step and do complete their differentia-
tion program before mouse death. Therefore, they have al-
lowed us to study the roles of Sox5 and Sox6 at each of these
steps. The two types of 3NA mice, Sox5
 / /Sox6
 /  and
Sox5
 / /Sox6
 /  mice, exhibit virtually identical growth plate
phenotypes, indicating that Sox5 and Sox6 are redundant in
all steps of chondrocyte maturation. They are more affected
than 2NA mice but less affected than 4NA mice, demon-
strating that the expression dosage of Sox5 and Sox6 is critical
for proper chondrogenesis. Sox5/Sox6 3NA mice resemble
Sox9
 /  mice (Bi et al., 2001) by the developmental delay
and matrix deficiency of cartilage primordia as well as by ec-
topic mineralization and bending of endochondral elements.
However, major differences can be noticed. The onset of car-
tilage mineralization is precocious in Sox9
 /  fetuses but de-
layed in Sox5/Sox6 3NA fetuses; endochondral elements are
short but not thin in Sox5/Sox6 3NA newborns and thin but
not always short in Sox9
 /  newborns; columnar zones are
short in Sox5/Sox6 3NA fetuses but normal in Sox9
 /  fe-
tuses; and hypertrophic zones are short in Sox5/Sox6 3NA fe-
tuses but long in Sox9
 /  fetuses. These differences are un-
likely due to the degree of severity of the phenotypes because
Sox5/Sox6 2NA, 3NA, and 4NA mice have qualitatively
Figure 8. Expression of regulatory genes 
in 3NA growth plates. Longitudinal 
sections through humeri of control and 
3NA embryos were hybridized at different 
ages with RNA probes for Runx2 (A), 
Pthrp (B), Ihh (C), Ptc1 (D), Fgfr3 (E), and 
Bmp6 (F), as indicated. Arrows, Ihh ex-
pression domain and positive gradient of 
Fgfr3 expression in the columnar zone.Sox5 and Sox6 control growth plate chondrocytes | Smits et al. 755
identical defects. Thus, Sox5, Sox6, and Sox9 must have dis-
tinct functions during chondrocyte maturation.
Source chondroblasts
The presence of a major chondroblast proliferation peak be-
tween epiphyses and metaphyses in fetal long bones leads us
to revisit the main cellular source of the growth plate. Most
studies with fetal growth plates have assumed that epiphyseal
chondroblasts (often referred to as reserve, resting, or periar-
ticular chondrocytes) give rise to columnar chondroblasts.
However, no definitive experimental evidence has validated
this model. In contrast, our data strongly suggest that epi-
physes elongate through cell proliferation mainly in the peri-
articular region and epiphyseal side of the major prolifera-
tion peak, and that columnar zones are generated and
renewed mainly by cells originating in the metaphyseal side
of this peak. Two pieces of data support our model. First,
sternum growth plates develop and are maintained in the ab-
sence of epiphyses. They present in pairs oriented back-to-
back and sharing a pool of intersternebral chondroblasts.
This pool is the likely equivalent of the major proliferation
peak in long bones. Second, long bone growth plates be-
come postnatally restricted to the region of the major prolif-
eration peak and metaphysis. They are physically separated
from articular cartilage by the secondary ossification centers
that develop in epiphyses. Therefore, their cellular source
cannot be in articular cartilage. Consistent with our model,
a study in rabbits has suggested that postnatal growth plates
find their cell source just above the columnar zone, in a zone
(called resting zone) that likely corresponds to the fetal
chondroblast proliferation peak (Abad et al., 2002).
Epiphyseal chondroblasts
When 4NA fetuses die, their epiphyses are still largely pre-
cartilaginous. In contrast, epiphyseal chondroblasts differen-
tiate with only a slight delay in 3NA embryos, and 3NA epi-
physes are essentially normal at birth. These data indicate
that epiphyseal chondroblasts require Sox5 and Sox6 for de-
velopment, but only at a low dosage. PTHrP/PPR signaling
prevents ectopic maturation of epiphyseal chondroblasts
(Lanske et al., 1996; Chung et al., 1998; Kobayashi et al.,
2002). Ectopic maturation of epiphyseal chondroblasts does
not occur in 3NA cartilages, which is consistent with the
normal expression of Ppr and Pthrp detected in these carti-
lages. Therefore, PTHrP/PPR signaling does not require
high levels of Sox5 and Sox6.
Columnar chondroblasts
3NA chondroblasts fail to proliferate at maximum levels at
the top of the columnar zone and decrease their proliferation
rate much faster than control cells. Thus, columnar chon-
droblasts require a high dosage of Sox5 and Sox6 to function
optimally, in contrast to epiphyseal chondroblasts. Never-
theless, Sox5 and Sox6 appear expressed at similar levels from
the joint area to the prehypertrophic zone (Lefebvre et
al., 1998; unpublished data), which means that their expres-
sion levels do not directly dictate the cell proliferation
changes. Ihh signaling stimulates chondroblast proliferation
(St-Jacques et al., 1999). However, because Ihh levels are
likely inversely proportional to the gradient of cell prolifera-
tion in the columnar zone, Ihh signaling probably attenuates
rather than generates this gradient. Interestingly, Ihh expres-
sion is not substantially altered in 3NA cartilages, and Ihh
signaling actually functions better in these cartilages than in
control cartilages. This result was revealed by up-regulation
and expansion of the expression domain of Ptc1. It has been
shown that proteoglycans or glycosaminoglycans facilitate the
movement of Ihh through tissues (Gritli-Linde et al., 2001).
Therefore, it is possible that the 3NA cartilage matrix defi-
ciency allows for a better diffusion of Ihh, and hence, for in-
creased signaling. The other possibility, that 3NA chondro-
blasts are more responsive to Ihh signaling, is not supported
by the fact that Ptc1 is also up-regulated in 3NA perichon-
drium and bone cells, which do not express Sox5 and Sox6.
Minina et al. (2001) have shown that BMP signaling is re-
quired in addition to Ihh signaling to maintain chondroblast
proliferation in limb explants, but a definitive role for BMP
signaling in columnar chondroblasts has not been demon-
strated in vivo. Nevertheless, inhibition of early chondro-
blast proliferation in Bmpr1b
 /  mice (Baur et al., 2000; Yi
et al., 2000) and continued expression of Bmpr1b and sev-
eral BMP genes in the growth plate and perichondrium
strongly suggest that BMP signaling must contribute to co-
lumnar chondroblast proliferation. Expression of BMP and
BMP receptor genes is not altered in 3NA cartilages, except
for Bmp6, which is expressed in prehypertrophic chondro-
cytes. Although the exact role of Bmp6 in growth plates has
not been fully determined (Solloway et al., 1998), Sox5 and
Sox6 appear to act upstream of BMP6 signaling, possibly in
controlling chondroblast proliferation.
Fgfr3 and Fgf18 negatively regulate chondroblast prolifer-
ation, acting at least in part by down-regulating Ihh expres-
sion and signaling (Colvin et al., 1996; Deng et al., 1996;
Naski et al., 1998; Liu et al., 2002; Minina et al., 2002; Oh-
bayashi et al., 2002). Fgf18 is expressed in the perichon-
drium, and its expression is unaffected in 3NA elements.
Fgfr3 is expressed in the columnar zone, and we found that
its expression follows a positive gradient from the top to the
bottom of this zone. This finding suggests that FGFR3 sig-
naling generates the negative gradient of columnar chondro-
blast proliferation. Interestingly, 3NA chondroblasts up-reg-
ulate Fgfr3 earlier than control cells in the columnar zone,
strongly suggesting that Sox5  and  Sox6 control columnar
chondroblast proliferation at least in part by delaying Fgfr3
up-regulation.
Chondrocyte prehypertrophy
In the cartilage primordia of future long bones, 3NA and
4NA chondroblasts activate the prehypertrophic marker Ppr
later than control cells when considering the gestation time.
However, when considering the time at which the cells be-
come chondroblastic, 3NA chondroblasts activate Ppr faster
than control cells. In the sternum primordium, activation of
Ppr occurs so early and is so widespread that it is truly ec-
topic. Thus, Sox5 and Sox6 are needed to delay chondrocyte
prehypertrophy. In seeking for the underlying mechanism,
we found that Sox5 and Sox6 are needed to delay and down-
regulate expression of the prehypertrophy inducer Runx2.
However, their mode of action is likely indirect because
Runx2 is also up-regulated in the perichondrium where Sox5756 The Journal of Cell Biology | Volume 164, Number 5, 2004
and Sox6 are not expressed. Significant changes in expression
of Pthrp and Ppr, which delay prehypertrophy, are not de-
tected in 3NA growth plates, indicating that Sox5 and Sox6
unlikely act upstream of PPR signaling. FGF signaling accel-
erates the onset and the pace of prehypertrophic chondro-
cyte differentiation in limb explants in vitro and BMP sig-
naling antagonizes the effect of FGF signaling (Minina et al.,
2002). Because Sox5 and Sox6 might control chondroblast
proliferation at least in part by delaying up-regulation of
Fgfr3 in columnar chondroblasts, they may similarly delay
prehypertrophy and may decrease the effect of FGF signal-
ing by up-regulating Bmp6.
Chondrocyte hypertrophy and terminal differentiation
Chondrocytes become hypertrophic with a significant delay in
3NA cartilage primordia, and then form short hypertrophic
zones because they terminally differentiate prematurely. In
4NA embryos, chondrocytes skip hypertrophy as seen namely
by failure to express Col10a1, the most specific marker of hy-
pertrophic chondrocytes, and directly differentiate from early
prehypertrophy to the terminal stage. This critical role of Sox5
and Sox6 in allowing chondrocytes to undergo hypertrophy
and in delaying terminal differentiation appears opposed to
that of Sox9, which may prevent chondrocyte hypertrophy
and accelerate terminal differentiation (Bi et al., 2001). Sox9 is
expressed at a normal level in 3NA and 4NA chondroblasts
and is correctly turned off in 3NA hypertrophic cells (Smits et
al., 2001; unpublished data). Therefore, it is not involved in
the phenotype of Sox5/Sox6 mutants. Because Sox5, Sox6 and
Sox9 are no longer expressed in hypertrophic chondrocytes,
their actions on these cells must be indirect. Runx2 is needed
for chondrocyte prehypertrophy and may still be needed for
hypertrophy because it was proposed to directly activate
Col10a1 (Zheng et al., 2003). Therefore, its up-regulation in
3NA cells is at odds with the impairment of hypertrophy, un-
less Runx2 promotes prehypertrophy but delays hypertrophy,
or cooperates with another yet unknown factor to specify
chondrocyte hypertrophy. The signaling pathways that pro-
mote chondrocyte hypertrophy are still unknown, but the
possibility that chondroblasts depend on Sox5 and Sox6 to ex-
press signaling molecules mediating hypertrophy of neighbor-
ing chondrocytes is not supported by observations made in
Sox9/Col2-Cre mutants (Akiyama et al., 2002). In these mu-
tants, cells in the core of cartilage primordia appear to un-
dergo normal differentiation up to and including hypertro-
phy, whereas all other cartilage cells remain prechondrocytic
and fail to activate Sox5 and Sox6. This suggests that chondro-
cyte hypertrophy is controlled cell autonomously. A mecha-
nism whereby Sox5 and Sox6 might be required cell autono-
mously but indirectly for chondrocyte hypertrophy might be
that chondroblasts need to surround themselves with a proper
cartilage matrix, a function promoted by Sox5 and Sox6, to be
able to undergo hypertrophy.
Despite hypertrophy impairment, 3NA and 4NA chon-
drocytes undergo terminal differentiation, a step that is not
yet fully understood at the regulatory level. Several works
have shown a block of chondrocyte differentiation at the
mineralizing stage, for instance upon inactivation of Mmp9
(Vu et al., 1998), Vegf (Gerber et al., 1999), Runx2 (Komori
et al., 1997; Otto et al., 1997), or Osx (Nakashima et al.,
2002), but these works have not demonstrated whether
chondrocytes are blocked at the hypertrophic or terminal
stage. We have shown that 3NA and 4NA chondrocytes ter-
minally differentiate only on contact with ossification fronts,
strongly suggesting that chondrocyte terminal differentia-
tion is induced at least in part by ossification fronts.
3NA cells undergo terminal differentiation even if they do
not reach full hypertrophy, and 4NA cells do so immediately
after reaching prehypertrophy, indicating that hypertrophy is
a dispensable step in the chondrocyte pathway. Thus, Sox5
and Sox6 allow chondrocytes to add hypertrophy in their
pathway, a step determinant for the proper elongation of en-
Figure 9. Proposed model for the roles of Sox5 
and Sox6 in chondrocytes. Sox5 and Sox6 are 
expressed in prechondrocytes, chondroblasts, and 
early prehypertrophic chondrocytes such that their 
mode of action at these stages must be direct or 
indirect (green and red solid lines). They are no 
longer expressed in late prehypertrophic, hyper-
trophic, and terminal chondrocytes, and therefore 
their mode of action at these stages must be indirect 
(red and green dashed lines). Sox5 and Sox6 act to 
promote (green arrows) the differentiation of pre-
chondrocytes into early chondroblasts and the 
subsequent differentiation of early chondroblasts 
into epiphyseal, source, or columnar chondroblasts. 
Sox5 and Sox6 also stimulate proliferation of all 
chondroblasts (curved arrows indicate cell prolifer-
ation and their thickness reflects proliferation rates). 
Sox5 and Sox6 maintain columnar chondroblasts 
proliferating and delay (red bars) prehypertrophic 
differentiation of early and columnar chondroblasts 
at least in part by delaying Fgfr3 up-regulation and 
by down-regulating Runx2. Finally, Sox5 and Sox6 
are needed to allow induction of chondrocyte 
hypertrophy and to delay terminal differentiation 
of prehypertrophic and hypertrophic chondrocytes 
induced by ossification fronts.Sox5 and Sox6 control growth plate chondrocytes | Smits et al. 757
dochondral elements. Here, they may also function by allow-
ing cells to accumulate extracellular matrix and thereby pro-
tect themselves against bone invasion. In agreement with this
model, 3NA sternum chondrocytes may be able to become
hypertrophic because they undergo prehypertrophy so mas-
sively that ossification fronts cannot invade them all at once.
Conclusions
This work has demonstrated essential, redundant roles for
Sox5 and Sox6 in chondrocyte differentiation and prolifera-
tion (Fig. 9) beyond their critical role in promoting differen-
tiation of prechondrocytes into early chondroblasts (Smits et
al., 2001). Sox5 and Sox6 ensure the development of early
chondroblasts into epiphyseal, source, and columnar chon-
droblasts and delay chondrocyte prehypertrophy. They stim-
ulate the proliferation of source chondroblasts, keep colum-
nar chondroblasts proliferating, and prevent precocious
prehypertrophy at least in part by delaying up-regulation of
Fgfr3 and by down-regulating Runx2. They are also needed
to allow development of hypertrophic chondrocytes and to
prevent precocious terminal differentiation of prehyper-
trophic and hypertrophic chondrocytes. Because they are no
longer expressed in chondrocytes beyond prehypertrophy,
their actions in hypertrophic and terminal chondrocytes
must be indirect, possibly extracellular matrix mediated.
Thus, Sox5 and Sox6 are required for the establishment of
cartilage growth plates and thereby for the proper and timely
development of endochondral bones.
Materials and methods
Generation of Sox5/Sox6 mutant mice
The generation and genotyping of Sox5/Sox6 mutant mice was previously
described (Smits et al., 2001). Mice were 129/SvEv   C57BL/6 hybrids,
and skeletal phenotypes were fully penetrant. 3 and 4NA mice were gener-
ated by crossing Sox5/Sox6 double heterozygous males with single or dou-
ble heterozygous females. All experiments were repeated with two or
more pairs of control and mutant littermates.
Skeleton staining, histology analysis, and RNA
in situ hybridization
Whole-mount staining of embryos, skeletal preparations, and histology
were performed as described previously (Smits et al., 2001). Samples from
control and mutant littermates were embedded in the same paraffin blocks
to minimize experimental variation. Sections stained with Alcian blue or
with the von Kossa reagent were counterstained with nuclear fast red. The
Bmp6 probe was an 893-bp EcoRI–SacI fragment of the mouse cDNA (a
gift from Y. Furuta, University of Texas, Houston, TX), the Mmp13 probe
was the first 699 nucleotides of the mouse cDNA, the Opn probe was a
1.3-kb EcoRI fragment of the rat cDNA (a gift from K. Nakashima and B. de
Crombrugghe, University of Texas, Houston, TX), and the Ptc1 probe was
the full-length mouse cDNA (a gift from R.L. Johnson, University of Texas,
Houston, TX). The Agc1 and Col10a1 probes (gifts from E. Vuorio, Univer-
sity of Turku, Turku, Finland), the Fgfr3 probe (a gift from C.X. Deng, Na-
tional Institutes of Health, Bethesda, MD), the Ihh probe (a gift from A.P.
McMahon, Harvard University, Cambridge, MA), the Mat1 probe (a gift
from A. Aszódi, Max-Planck Institute, Martinsried, Germany), the Mmp9
probe (a gift from Z. Werb, University of California, San Francisco, San
Francisco, CA), the Ppr probe (a gift from H.M. Kronenberg, Massachusetts
General Hospital, Boston, MA), and the Runx2 probe (a gift from G.
Karsenty, Baylor College of Medicine, Houston, TX) were as described pre-
viously (Smits et al., 2001).
Cell proliferation assay
Pregnant mice were injected with BrdU reagent (Zymed Laboratories; 10
 l/g of mouse) and killed 2 h later. BrdU-labeled nuclei were detected by
immunostaining (Zymed Laboratories), and sections were counterstained
with hematoxylin, as described previously (Smits and Lefebvre, 2003). Cell
proliferation rates were determined by counting the percentages of BrdU-
positive cells in consecutive segments distributed from the periarticular to
the hypertrophic zone of growth plates. Reproducible data were obtained
with three sets of control and mutant littermates.
Image acquisition and manipulation
Samples were visualized on a microscope (model BX50; Olympus)
equipped with Uplanapo 10 /0.40 and Uplanapo 20 /0.70;  ∞/0.17
lenses (Olympus). Images were captured with a digital camera (model
DMC2; Polaroid) using accompanying software. In situ hybridization im-
ages were taken under dark field using a red filter for RNA signals and un-
der blue fluorescence for nuclei stained with Hoechst 33258 dye. Figures
were composed using Adobe Photoshop 7.0.
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